ACTIVIN RECEPTOR LIGAND FOR THR TREATMENT OF BETA-THALASSEMIA: a SERENDIPITOUS DISCOVERY
b-thalassemia is a hereditary disorder caused by defective production of b-globin chains of hemoglobin (Hb) that leads to an increased a/b globins ratio with subsequent free a-globins. Alpha globin excess causes oxidative stress, RBCs membrane damage, premature death of late-stage erythroid precurso...
Saved in:
| Main Authors: | Irene Motta, Valentina Brancaleoni, Isabella Nava, Paola Delbini, Lorena Duca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2020-10-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/4358 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pseudo-sérendipité et contre-sérendipité dans les conceptions temporelles révolutionnaires
by: Olivier Lamoureux-Lafleur
Published: (2017-03-01) -
Elritercept, a modified activin receptor IIA ligand trap, increased erythropoiesis and thrombopoiesis in a phase 1 trial
by: Jennifer Lachey, et al.
Published: (2025-01-01) -
Thyroid hormone receptor beta (THRβ1) is the major regulator of T3 action in human iPSC-derived hepatocytes
by: Lorraine Soares De Oliveira, et al.
Published: (2024-12-01) -
Le modèle de la sérendipité
by: Robert K. Merton
Published: (2017-03-01) -
Activins and Inhibins in Cardiovascular Pathophysiology
by: Wenyi Tang, et al.
Published: (2024-11-01)